NCT07166874

Brief Summary

Subclinical intestinal inflammation and intestinal permeability have been reported in patients with ankylosing spondylitis. Gluten is one of the main triggers of zonulin releaseand gluten intake may contribute to the development of the disease by increasing intestinal permeability. This study aims to determine the impacts of a gluten-freediet on intestinal permeability, sub-clinical intestinal inflammation, disease activity, functional status and quality of life in patients with ankylosing spondylitis. The main questions it aims to answer are: Does a gluten-free diet have an effect on disease activity and functional status in patients with ankylosing spondylitis? Does a gluten-free diet have an effect on intestinal permeability and subclinical intestinal inflammation in patients with ankylosing spondylitis? The investigators will evaluate the effects of the gluten-free diet compared to a control group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jan 2025

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2025May 2026

Study Start

First participant enrolled

January 31, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

August 26, 2025

Last Update Submit

September 3, 2025

Conditions

Keywords

gluten free dietintestinal permeabilityzonulinankylosing spondylitiscytokineBASDAI

Outcome Measures

Primary Outcomes (2)

  • effects of a 8-week Gluten Free Diet versus placebo diet on fasting serum zonulin levels

    Serum zonulin will be evaluated as a biomarker of intestinal permeability. It will be measured by ELISA(enzyme-linked immunosorbent assay) method.

    Change from baseline serum zonulin at 8 weeks

  • effects of a 8-week Gluten Free Diet versus placebo diet on fasting serum LPS levels

    Serum LPS will be evaluated as a biomarker of intestinal permeability. It will be measured by ELISA(enzyme-linked immunosorbent assay) method.

    Change from baseline serum LPS at 8 weeks

Secondary Outcomes (15)

  • effects of a 8 week Gluten Free Diet versus placebo diet on the activity of Ankylosing Spondylitis evaluated by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).

    Change from baseline BASDAI score at 8 weeks

  • effects of a 8-week Gluten Free Diet versus placebo diet on functional disability asssessed by Bath Ankylosing Spondylitis Functionnal Index (BASFI) questionnaire

    Change from baseline BASFI score at 8 weeks

  • effects of a 8 week Gluten Free Diet versus placebo diet on the quality of life of Ankylosing Spondylitis evaluated by the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL).

    Change from baseline ASQoL score at 8 weeks

  • effects of a 8-week Gluten Free Diet versus placebo diet on CRP levels

    Change from baseline CRP at 8 weeks

  • effects of a 8-week Gluten Free Diet versus placebo diet on ESR levels

    Change from baseline ESR at 8 weeks

  • +10 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

In the control arm, patients will continue their eating habits.

Gluten Free Diet

EXPERIMENTAL

Patients in the experimental arm will received a gluten-free diet for 8 weeks.

Behavioral: Gluten Free Diet

Interventions

Patients in the experimental arm will received a gluten-free diet for 8 weeks.

Gluten Free Diet

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of axial SpA defined by ASAS criteria
  • Adults (aged 18-64 years)
  • stable treatment (NSAID and/or DMARD) for at least 3 months
  • provide written informed consent and submit to the requirements of the study

You may not qualify if:

  • have a history of celiac disease;
  • have a history of Ulcerative Colitis, Crohn's Disease and Irritable Bowel Syndrom
  • patients with Type 1 and Type 2 Diabetes Mellitus
  • patients with Hashimoto Thyroiditis
  • are pregnant, breastfeeding,
  • patients who have used omega-3 and vitamins (A, C, E) regularly in the last 3 months.
  • BMI \<18,50 kg/m2
  • BMI ≥29,99 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Bakırköy Dr. Sadi Konuk Training and Research hospital

Istanbul, Turkey (Türkiye)

RECRUITING

İstanbul Medeniyet University

Istanbul, Turkey (Türkiye)

ACTIVE NOT RECRUITING

İstanbul Sağlık Bilimleri University

Istanbul, Turkey (Türkiye)

ACTIVE NOT RECRUITING

Marmara University

Istanbul, Turkey (Türkiye)

ACTIVE NOT RECRUITING

MeSH Terms

Conditions

Spondylitis, Ankylosing

Interventions

Diet, Gluten-Free

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dietitian

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 10, 2025

Study Start

January 31, 2025

Primary Completion

December 30, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations